Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 2,4012,420 of 20,252 grants

Completed SBIR-STTR RPGS
A democratized platform for mapping the spatial epigenome in tissue
NATIONAL CANCER INSTITUTE Atlasxomics Inc United States 2023 – 2025

PROJECT SUMMARY AtlasXomics Inc. is commercializing the next generation of spatial biology tools to help researchers understand the epigenetic mechanisms of disease. The goal of th...

$13.91M
USD
Active NON-SBIR/STTR RPGS
Imaging, Dosimetry and Radiobiology for α-particle Emitter Radiopharmaceutical Therapy
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Treatment for almost all patients with metastatic cancer has become a balance between managing often severe, treatment-induced toxicity and preventing cancer progression. Progressi...

$26.24M
USD
Active NON-SBIR/STTR RPGS
Alpha-emitter Imaging for Dosimetry and Treatment Planning
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Radiopharmaceutical therapy with α-particle emitters (αRPT) is a highly effective cancer therapy modality; it delivers potent alpha-particle radiation to cancer cells and is theref...

Active RESEARCH CENTERS
Research Project 1
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

Cervical cancer is the leading cause of cancer-related deaths in South Africa where incidence and mortality rates are expected to rise, in part due to the largest global burden of...

Active RESEARCH CENTERS
Research Project 2
NATIONAL CANCER INSTITUTE Columbia University Health Sciences United States 2023 – 2028

Cervical cancer is the leading cause of cancer-related deaths among women in low and middle-income countries (LMICs) and a key contributor to global disparities in cancer incidence...

Active NON-SBIR/STTR RPGS
Microscale Radionuclide S-values for αRPT
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Abstract / Summary – Project 2 Radiopharmaceuticals labeled with alpha-particle emitters (RPT) uniquely satisfy various conditions for therapy of cancer in its advanced stages. Al...

Active NON-SBIR/STTR RPGS
Precision Risk Stratification and Screening for HCC among Patients with Indeterminate Liver Nodules
NATIONAL CANCER INSTITUTE Ut Southwestern Medical Center United States 2023 – 2028

PROJECT SUMMARY Large gaps in current strategies for risk stratification and surveillance contribute to frequent late-stage detection and poor outcomes in patients with hepatocellu...

$9.07M
USD
Active NON-SBIR/STTR RPGS
Macro-to-micro (M2µ) Activity Apportionment for αRPT
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Recent advances in the targeted delivery of radionuclides and the increased availability of -emitters appropriate for clinical use have led to patient trials of multiple α-emitter...

Active RESEARCH CENTERS
Project 2 Human Tumor Analysis
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

SUMMARY/ABSTRACT: PROJECT 2 Metastasis is the primary cause of cancer-related death. Our recent evidence establishes a new paradigm, “lymph node tolerization,” in which the lymph n...

Active RESEARCH CENTERS
Outreach Core
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT – Outreach Core The Stanford CCSB is committed to advancing and promoting systems biology approaches to cancer research. The Outreach Core will coordinate scientific outre...

Active RESEARCH CENTERS
Biospecimen and Data Core
NATIONAL CANCER INSTITUTE Stanford University United States 2023 – 2028

ABSTRACT/SUMMARY: BIOSPECIMEN AND DATA CORE Our CCSB will dissect how interactions between malignant, stromal and immune cells in the primary tumor and lymph nodes (LN) influence s...

Active NON-SBIR/STTR RPGS
Targeting Pediatric Cancer Vulnerabilities
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2030

Project Summary / Abstract Despite progress in understanding the molecular basis of childhood malignancies, cancer remains the leading cause of disease-related death in school age...

$10.66M
USD
Active NON-SBIR/STTR RPGS
Identifying and exploiting therapeutic vulnerabilities of tumor-host interactions that drive bone-to-meninges breast cancer metastasis
NATIONAL CANCER INSTITUTE Duke University United States 2023 – 2028

Leptomeningeal (LM) metastases occur in a wide variety of hematologic and solid malignancies, including leukemia, breast cancer (BC), and lung cancer. When LM metastases arise, the...

$5.2M
USD
Active NON-SBIR/STTR RPGS
Administrative
NATIONAL CANCER INSTITUTE Johns Hopkins University United States 2023 – 2028

Project Summary The Administrative Core is responsible for the managerial oversight of the P01. This includes all administrative and budgetary matters, scheduling advisory committe...

Active OTHER RESEARCH-RELATED
Dissecting the role of DNA damage repair deficiency in Ewing sarcoma pathogenesis for improved risk stratification and treatment
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2023 – 2028

PROJECT SUMMARY Ewing sarcoma is the second most common bone and soft tissue cancer impacting children and adolescents worldwide. It is an aggressive malignancy requiring multimoda...

$2.08M
USD
Active RESEARCH CENTERS
Administrative Core
NATIONAL CANCER INSTITUTE San Diego State University United States 2023 – 2028

PROJECT SUMMARY/ ABSTRACT – ADMINISTRATIVE CORE The goal of the Administrative Core of the Cancer Research and Education to Advance HealTh Equity (CREATE) Partnership is to provide...

Active RESEARCH CENTERS
Project 1: Defining Mechanisms of MICAL-dependent Pancreatic Cancer Cell Migration
NATIONAL CANCER INSTITUTE San Diego State University United States 2023 – 2028

PROJECT SUMMARY/ ABSTRACT – PROJECT 1 Pancreatic duct adenocarcinoma (PDAC) takes the life of an American approximately every 12 minutes and disproportionately affects African Amer...

Active RESEARCH CENTERS
Project 2: The Intersection of Telehealth and Health Disparities in At-Risk Older Patients with Cancer
NATIONAL CANCER INSTITUTE San Diego State University United States 2023 – 2028

PROJECT SUMMARY/ ABSTRACT – PROJECT 2 Telehealth utilization increased rapidly across the US healthcare system in response to the COVID-19 pandemic. As we emerge from the pandemic,...

Active NON-SBIR/STTR RPGS
Implementing the NYU Electronic Patient Visit Assessment (ePVA) for Head and Neck Cancer In Rural and Urban Populations
NATIONAL CANCER INSTITUTE University of Texas Hlth Sci Ctr Houston United States 2023 – 2028

ABSTRACT Approximately 66,000 individuals will be diagnosed with head and neck cancer (HNC) in the United States (US) in 2022. Most patients with HNC are treated aggressively with...

$7.34M
USD
Active NON-SBIR/STTR RPGS
CHOLESTEROL METABOLISM IN THE PHARMACOLOGY OF LIPOSOMAL THERAPEUTICS
NATIONAL CANCER INSTITUTE Texas Tech University Health Scis Center United States 2023 – 2028

ABSTRACT Drug delivery using liposomes increases tumor drug accumulation while sparing normal tissue. Several liposomal chemotherapies are approved to treat cancer. Unfortunately,...

$4.97M
USD